American Century Companies’s Solid Biosciences SLDB Stock Holding History

American Century Companies's SLDB Position: Q2 2026 in Review

American Century Companies reduced its Solid Biosciences (SLDB) stake by 46% in Q2 2026, selling an estimated $396K and leaving 62,211 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #2536.

American Century Companies first reported a position in SLDB in Q1 2024 and has held it in 10 quarters since. The position peaked at $824K in Q1 2026. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

• American Century Companies held 62,211 shares of Solid Biosciences worth $621K as of Q2 2026.
• American Century Companies sold 52,181 Solid Biosciences shares in Q2 2026, an estimated $396K.
• Solid Biosciences made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2536 holding.
• American Century Companies first reported a position in Solid Biosciences in Q1 2024 and has held it in 10 quarters since.
• American Century Companies's Solid Biosciences position peaked at $824K in Q1 2026.
• 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.